Biotechnology Value Fund L P

13F Holdings History for MoonLake Immunotherapeutics - Class A Ordinary Shares, par value $0.0001 per share (MLTX)

Symbol: MLTX on Nasdaq
Investment type: Equity / Class A Ordinary Shares, par value $0.0001 per share
Latest Disclosed Ownership: 19.8M shares
Security Ownership: 27.7%

BVF PARTNERS L P/IL ownership in MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX)

2025-11-10 - BVF PARTNERS L P/IL has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 19.8M shares of MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX). This represents 27.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BVF PARTNERS L P/IL	27.7%		$142M	19.8M			$7.17	13D/A	11/6/2025	10 Nov 2025 17:27:37